MTA vs Biodentine in Symptomatic Irreversible Pulpitis Treatment
This study aims to compare the short-term effectiveness of MTA and Biodentine in treating symptomatic irreversible pulpitis through a complete pulpotomy procedure, measuring clinical outcomes with Electric Pulp Testing and radiographic outcomes with the Periapical Index.
Biodentine pulpotomy
Treatment Study
Summary
Study start date: November 2, 2024
Actual date on which the first participant was enrolled.This study focuses on individuals who visit the Operative Dentistry Department with pain in their back teeth. The main goal is to compare the short-term results of two different materials, MTA and Biodentine, used in a procedure called complete pulpotomy. This procedure is typically performed when the pulp, the soft part inside the tooth, is infected and causing pain. The study aims to find out which material is more effective in treating this condition, potentially improving dental care for those suffering from symptomatic irreversible pulpitus. During the study, participants will have their medical and dental history recorded, and the affected tooth will be thoroughly examined. The procedure will be performed by a single dentist in two visits. After numbing the area with an injection, the dentist will remove the infected pulp and apply either MTA or Biodentine inside the tooth. A temporary filling will be placed, and the participant will return the next day for a final filling. An X-ray will be taken to check the result. Participants may take ibuprofen if they experience pain afterwards, and are asked to return for follow-ups after 1 day, 1 week, 1 month, and 3 months. The success of the treatment will be evaluated through electric pulp testing and radiographic outcome measure using a Periapical Index.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Dr Khadija Zubair
Karachi, Pakistan